nach oben

Current Fungal Infection Reports

Erschienen in:

20.07.2018 | Fungal Infections of Skin and Subcutaneous Tissue (A Bonifaz, Section Editor)

Tinea Capitis: Current Review of the Literature

verfasst von: Andrés Tirado-Sánchez, Alexandro Bonifaz

Erschienen in: Current Fungal Infection Reports | Ausgabe 3/2018

Einloggen, um Zugang zu erhalten

Abstract

Purpose of Review

This review summarizes the fungal literature currently available for tinea capitis (TC), as well as providing data for clinical utility.

Recent Findings

Available studies in TC are scarce; however, they provide important information about efficacy and outcome in clinical practice.

Summary

Treatment of TC is effective; however, it requires a minimum of 1 month. Systemic treatment is often required to favor enhance drug penetration into the deep part of the hair follicle. The newest oral antifungal has higher efficacy rates than conventional therapy, as well as much shorter duration of treatment but at higher costs. We perform a review of the literature including treatment schemes.

Bennassar A, Grimalt R. Management of tinea capitis in childhood. Clin Cosmet Investig Dermatol. 2010;3:89–98.PubMedPubMedCentral

• Rebollo N, López-Barcenas AP, Arenas R. Tinea capitis. Actas Dermosifiliogr. 2008;99(2):91–100. This paper is an overview of the disease. CrossRefPubMed

Hay RJ, Robles W, Midgley G, Moore MK. European Confederation of Medical Mycology Working Party on Tinea Capitis. Tinea capitis in Europe: new perspective on an old problem. J Eur Acad Dermatol Venereol. 2001;15(3):229–33.CrossRefPubMed

• Kallel A, Hdider A, Fakhfakh N, Belhadj S, Belhadj-Salah N, Bada N, et al. Tinea capitis: main mycosis child. Epidemiological study on 10 years. J Mycol Med. 2017;27(3):345–50. This paper showed the most common clinical manifestations of tinea capitis in children. CrossRefPubMed

Ziegler W, Lempert S, Goebeler M, Kolb-Mäurer A. Tinea capitis: temporal shift in pathogens and epidemiology. J Dtsch Dermatol Ges. 2016;14(8):818–25. (Abstract)PubMed

Kieliger S, Glatz M, Cozzio A, Bosshard PP. Tinea capitis and tinea faciei in the Zurich area - an 8-year survey of trends in the epidemiology and treatment patterns. J Eur Acad Dermatol Venereol. 2015;29(8):1524–9.CrossRefPubMed

Sei Y. 2011 epidemiological survey of dermatomycoses in Japan. Med Mycol J. 2015;56(4):J129–35.CrossRefPubMed

• Brito-Santos F, Figueiredo-Carvalho MHG, Coelho RA, Sales A, Almeida-Paes R. Tinea capitis by Microsporum audouinii: case reports and review of published global literature 2000‑2016. Mycopathologia. 2017;182(11–12):1053–60. An important review of the disease mainly on therapeutic options CrossRefPubMed

Niczyporuk W, Krajewska-Kułak E, Łukaszuk C. Tinea capitis favosa in Poland. Mycoses. 2004;47(5–6):257–60.CrossRefPubMed

10.

Khosravi AR, Shokri H, Vahedi G. Factors in etiology and predisposition of adult tinea capitis and review of published literature. Mycopathologia. 2016;181(5–6):371–8.CrossRefPubMed

11.

•• Hay RJ. Tinea capitis: current status. Mycopathologia. 2017;182(1–2):87–93. This paper gives important strategies for treating tinea capitis. CrossRefPubMed

12.

Martínez-Suárez H, Guevara-Cabrera N, Mena C, Valencia A, Araiza J, Bonifaz A. Tiña de la cabeza. Reporte de 122 casos. Derma CMQ. 2007;5(1):9–14.

13.

Bonifaz A, Carrasco-Gerard E, Palacios-López C, Araiza J. Tratamiento de la cabeza con dosis intermitentes (semanales) de fluconazol. Derma Cosmet Med Quir. 2003;1:11–9.

14.

Gupta AK, Summerbell RC. Tinea capitis. Med Mycol. 2000;38(4):255–87.CrossRefPubMed

15.

Ilkit M, Demirhindi H. Asymptomatic dermatophyte scalp carriage: laboratory diagnosis, epidemiology and management. Mycopathologia. 2008;165(2):61–71.CrossRefPubMed

16.

Zurita J, Hay RJ. Adherence of dermatophyte microconidia and arthroconidia to human keratinocytes in vitro. J Investig Dermatol. 1987;89(5):529–34.CrossRefPubMed

17.

Sriranganadane D, Waridel P, Salamin K, Feuermann M, Mignon B, Staib P, et al. Identification of novel secreted proteases during extracellular proteolysis by dermatophytes at acidic pH. Proteomics. 2011;11(22):4422–33.CrossRefPubMed

18.

Staib P, Zaugg C, Mignon B, Weber J, Grumbt M, Pradervand S, et al. Differential gene expression in the pathogenic dermatophyte Arthroderma benhamiae in vitro versus during infection. Microbiology. 2010;156(Pt3):884–95.CrossRefPubMed

19.

Niyonsaba F, Ogawa H. Protective roles of the skin against infection: implication of naturally occurring human antimicrobial agents beta-defensins, cathelicidin LL-37 and lysozyme. J Dermatol Sci. 2005;40(3):157–68.CrossRefPubMed

20.

Abdelaal NH, Rashed LA, Ibrahim SY, Abd El Halim MH, Ghoneim N, Saleh NA, et al. Cathelicidin (LL-37) level in the scalp hair of patients with tinea capitis. Med Mycol. 2017;55(7):733–6.PubMed

21.

Mao L, Zhang L, Li H, Chen W, Wang H, Wu S, et al. Pathogenic fungus Microsporum canis activates the NLRP3 inflammasome. Infect Immun. 2014;82(2):882–92.CrossRefPubMedPubMedCentral

22.

Wagner DK, Sohnle PG. Cutaneous defenses against dermatophytes and yeasts. Clin Microbiol Rev. 1995;8(3):317–35.PubMedPubMedCentralCrossRef

23.

Calderon RA, Hay RJ. Fungicidal activity of human neutrophils and monocytes on dermatophyte fungi, Trichophyton quinckeanum and Trichophyton rubrum. Immunology. 1987;61(3):289–95.PubMedPubMedCentral

24.

Sakuragi Y, Sawada Y, Hara Y, Ohmori S, Omoto D, Haruyama S, et al. Increased circulating Th17 cell in a patient with tinea capitis caused by Microsporum canis. Allergol Int. 2016;65(2):215–6.CrossRefPubMed

25.

Gorgievska-Sukarovska B, Skerlev M, Žele-Starčević L, Husar K, Halasz M. Kerion celsi due to Microsporum canis with a dermatophytid reaction. Acta Dermatovenerol Croat. 2017;25(2):151–4.PubMed

26.

Brissos J, Gouveia C, Neves C, Varandas L. Remember kerion celsi. BMJ Case Rep. 2013;2013

27.

de Hoog GS, Dukik K, Monod M, Packeu A, Stubbe D, Hendrickx M, et al. Toward a novel multilocus phylogenetic taxonomy for the dermatophytes. Mycopathologia. 2017;182(1–2):5–31.CrossRefPubMed

28.

Farooqi M, Tabassum S, Rizvi DA, Rahman A, Rehanuddin, Awan S, et al. Clinical types of tinea capitis and species identification in children: an experience from tertiary care centres of Karachi, Pakistan. J Pak Med Assoc. 2014;64(3):304–8.PubMed

29.

Kefalidou S, Odia S, Gruseck E, Schmidt T, Ring J, Abeck D. Wood’s light in Microsporum canis positive patients. Mycoses. 1997;40(11–12):461–3.CrossRefPubMed

30.

Robert R, Pihet M. Conventional methods for the diagnosis of dermatophytosis. Mycopathologia. 2008;166(5–6):295–306.CrossRefPubMed

31.

Symoens F, Jousson O, Planard C, Fratti M, Staib P, Mignon B, et al. Molecular analysis and mating behaviour of the Trichophyton mentagrophytes species complex. Int J Med Microbiol. 2011;301(3):260–6.CrossRefPubMed

32.

Kanbe T, Suzuki Y, Kamiya A, Mochizuki T, Kawasaki M, Fujihiro M, et al. Species-identification of dermatophytes Trichophyton, Microsporum and Epidermophyton by PCR and PCR-RFLP targeting of the DNA topoisomerase II genes. J Dermatol Sci. 2003;33(1):41–54.CrossRefPubMed

33.

Brillowska-Dabrowska A, Michałek E, Saunte DM, Nielsen SS, Arendrup MC. PCR test for Microsporum canis identification. Med Mycol. 2013;51(6):576–9.CrossRefPubMed

34.

Verrier J, Krähenbühl L, Bontems O, Fratti M, Salamin K, Monod M. Dermatophyte identification in skin and hair samples using a simple and reliable nested polymerase chain reaction assay. Br J Dermatol. 2013;168(2):295–301.CrossRefPubMed

35.

Deng S, Zhou Z, de Hoog GS, Wang X, Abliz P, Sun J, et al. Evaluation of two molecular techniques for rapid detection of the main dermatophytic agents of tinea capitis. Br J Dermatol. 2015;173(6):1494–500.CrossRefPubMed

36.

Deng S, de Hoog GS, Verweij PE, Zoll J, Ilkit M, Morsali F, et al. In vitro antifungal susceptibility of Trichophyton violaceum isolated from tinea capitis patients. J Antimicrob Chemother. 2015;70(4):1072–5.PubMed

37.

Brasileiro A, Campos S, Cabete J, Galhardas C, Lencastre A, Serrão V. Trichoscopy as an additional tool for the differential diagnosis of tinea capitis: a prospective clinical study. Br J Dermatol. 2016;175(1):208–9.CrossRefPubMed

38.

Elghblawi E. Tinea capitis in children and trichoscopic criteria. Int J Trichology. 2017;9(2):47–9.PubMedPubMedCentral

39.

Lu M, Ran Y, Dai Y, Lei S, Zhang C, Zhuang K, et al. An ultrastructural study on corkscrew hairs and cigarette-ash-shaped hairs observed by dermoscopy of tinea capitis. Scanning. 2016;38(2):128–32.CrossRefPubMed

40.

Schechtman RC, Silva ND, Quaresma MV, Bernardes Filho F, Buçard AM, Sodré CT. Dermatoscopic findings as a complementary tool in the differential diagnosis of the etiological agent of tinea capitis. An Bras Dermatol. 2015;90(3 Suppl 1):13–5.CrossRefPubMedPubMedCentral

41.

Campos S, Brasileiro A, Galhardas C, Apetato M, Cabete J, Serrão V, et al. Follow-up of tinea capitis with trichoscopy: a prospective clinical study. J Eur Acad Dermatol Venereol. 2017;31(11):e478–80.CrossRefPubMed

42.

Arrazola-Guerrero J, Isa-Isa R, Torres-Guerrero E, Arenas R. Tinea capitis. Dermoscopic findings in 37 patients. Rev Iberoam Micol. 2015;32(4):242–6.CrossRefPubMed

43.

Velho GD, Selores M, Amorim I, Lopes V. Guess what! Tinea capitis by Trichophyton schöenleinii. Eur J Dermatol. 2001;11(5):481–2.PubMed

44.

Fuller LC, Barton RC, Mohd Mustapa MF, Proudfoot LE, Punjabi SP, Higgins EM. British Association of Dermatologists’ guidelines for the management of tinea capitis 2014. Br J Dermatol. 2014;171(3):454–63.CrossRefPubMed

45.

Chen X, Jiang X, Yang M, González U, Lin X, Hua X, et al. Systemic antifungal therapy for tinea capitis in children. Cochrane Database Syst Rev. 2016;5:CD004685.

46.

•• Chen X, Jiang X, Yang M, Bennett C, González U, Lin X, et al. Systemic antifungal therapy for tinea capitis in children: an abridged Cochrane review. J Am Acad Dermatol. 2017;76(2):368–74. An important paper that summarizes the clinical trials available for tinea capitis CrossRefPubMed

47.

Tey HL, Tan AS, Chan YC. Meta-analysis of randomized, controlled trials comparing griseofulvin and terbinafine in the treatment of tinea capitis. J Am Acad Dermatol. 2011;64(4):663–70.CrossRefPubMed

48.

Shemer A, Grunwald MH, Gupta AK, Lyakhovitsky A, Daniel CR 3rd, Amichai B. Griseofulvin and fluconazole reduce transmission of tinea capitis in schoolchildren. Pediatr Dermatol. 2015;32(5):696–700.CrossRefPubMed

49.

Danielli LJ, Lopes W, Vainstein MH, Fuentefria AM, Apel MA. Biofilm formation by Microsporum canis. Clin Microbiol Infect. 2017;23(12):941–2.CrossRefPubMed

50.

Shemer A, Plotnik IB, Davidovici B, Grunwald MH, Magun R, Amichai B. Treatment of tinea capitis - griseofulvin versus fluconazole - a comparative study. J Dtsch Dermatol Ges. 2013;11(8):737–41–2. (Abstract)

51.

Kakourou T, Uksal U, European Society for Pediatric Dermatology. Guidelines for the management of tinea capitis in children. Pediatr Dermatol. 2010;27(3):226–8.CrossRefPubMed

52.

Papaiordanou F, da Silveira BR, Abulafia LA. Hypersensitivity reaction to Sporothrix schenckii: erythema nodosum associated with sporotrichosis. Rev Soc Bras Med Trop. 2015;48(4):504.CrossRefPubMed

Titel: Tinea Capitis: Current Review of the Literature
verfasst von: Andrés Tirado-Sánchez
Alexandro Bonifaz
Publikationsdatum: 20.07.2018
Verlag: Springer US
Erschienen in: Current Fungal Infection Reports / Ausgabe 3/2018
Print ISSN: 1936-3761
Elektronische ISSN: 1936-377X
DOI: https://doi.org/10.1007/s12281-018-0320-2

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Tinea Capitis: Current Review of the Literature